2021 Subject Index
PDF

Other

2021 Subject Index

Bull Urooncol 2021;20(4):0-0
PDF
Permissions

12-core prostate biopsy scheme 19

5-hydroxyuracil incision 45

Adenocarcinoma 196

Adjuvant chemotherapy 96

Adjuvant intraluminal therapy 129

Adjuvant treatments 264

ADMA 107

Aging 133

AMACR/P504S 92

Anxiety 7

Arginine 107

Autologous stem-cell transplantation 258

Awareness month 142

Base excision repair 45

Benign prostatic hyperplasia 71

Bilateral 56

Biopsy 15, 83

Bladder 179

Bladder cancer 34, 40, 107, 168, 174, 206, 264

Breast cancer 142

Cancer 133

Cancer prognosis 252

Cancer-specific survival 174

Case report 192

Castration sensitive 1

Chemotherapy 1, 67, 258

Children 200

Chromophobe 273

Chromosome translocation 122

Chronic pyelonephritis 192

Cisplatin 67

Citrulline 107

Clinically insignificant prostate cancer 19

Clinically significant prostate cancer 215

Cognitive fusion 15

Colorectal malignancies 179

Comorbidity 73

Complication 111

Continence 236

Coronavirus 206

COVID-19 206

Creatinine 242

Cystectomy 168

Detection 11

Diabetes mellitus 162

Eccrine porocarcinoma 186

Elderly 73

Emergency 276

Endoscopy 236

Epstein criteria 19

Fiducial marker 158

Geriatrics 133

Germ cell testicular cancer 67

Gleason grade 26

Glomerular filtration rates 242

Google trends 142

Granulomatous orchitis 126

Haematuria 34

Haematuria duration 34

Haematuria frequency 34

Health status 73

High-risk carcinoma 219

Histology 236

Hybrid tumor 273

Index lesion 147

Intravesical BCG 206

İrradiation 219

L-NMMA 107

Low-grade 273

Lymph node involvement 174

Lymphocyte 168

Lymphovascular invasion 174

Malignancy 126

Malignant eccrine poroma 186

Metachronous 56

Metachronous neoplasms 49

Metastasectomy 270

Metastases 231

Metastasis 270

Metformin 162

Mid-term follow-up 117

MiT family carcinomas 122

MRI US Fusion 11

MRI-ultrasound fusion 210

multiparametric magnetic resonance imaging 15, 147

Neoadjuvant chemotherapy 264

Neoadjuvant hormonal treatment 219

Neobladder 236

Nephrectomy volüme 247

Nephrometry score 242

Nephron-sparing surgery 247

Neutrophil 168

Non-muscle-invasive bladder cancer 45

Non-tumor factors 247

Non-urothelial bladder carcinomas 96

Oncocytic tumor 273

Oncological outcomes 96

Overall survival 174, 252

Pain score 7

Pandemic 206

Paratesticular rhabdomyosarcoma 200

Partial cystectomy 196

Partial nephrectomy 111, 242

Pediatric 189

Peritoneal metastases 179

PI-RADS 147

Poroid neoplasm 186

Positive surgical margin 26

Predictors 111

Preoperative 276

Progression 40, 45

Prostate biopsy 11, 87, 138, 210

Prostate cancer 1, 11, 19, 83, 87, 92, 73, 142, 153, 158, 162, 210, 219, 225, 231, 264, 270

Prostate neoplasms 147

Prostate-specific antigen 215

PSA 92

PSA density 215

Questionnaire 133

Radical cystectomy 96

Radical inguinal orchiectomy 200

Radical nephrectomy 276

Radical prostatectomy 19, 26, 87, 147, 219, 225, 231, 280

Radiotherapy 158, 162, 225, 258

Recurrence 40, 270

Recurrence-free survival 231

Renal cell cancer 111

Renal cell carcinoma 49, 117, 122, 186, 247, 273

Renal mass 192

Renal tumor 242

Renal-sparing approach 129

Resection 179

Resection technique 111

Retropubic radical prostatectomy 153

Risk factors 40

Robotic assisted laparoscopic prostatectomy 71

Robotic prostatectomy 153

Robotic surgery 71, 280

Rupture 276

SDMA 107

Seconder primary malignant tumour 49

Sertoliform cystadenoma 189

Sexual function 138

Side effects 162

Signet-ring cell carcinoma 196

Spontaneous 276

Standard biopsy prostate cancer 15

Stereotactic 158

Stroke 67

Surgical margin positivity 231

Surgical technique 153

Surgical treatment 247

Survival 117

Sweat gland tumour 186

Synchronous 56

Synchronous neoplasms 49

Systemic immune-inflammation index 252

Targeted biopsy 11, 210

Testicle 126

Testicular cancer 252, 264

Testicular dysgenesis syndrome 56

Testicular germ cell tumors 258

Testicular germ cell tumour 56

Testis tumors 200

Testis-sparing surgery 189, 200

Thromboembolism 67

Translocation renal cell carcinoma 122

Transrectal ultrasound-guided prostate biopsy 7

Treatment 1

Unclassified renal cell carcinoma 117

Upgrading 87

Upper urinary tract urethelial tumor 129

Ureter 179

Urinary bladder 196

Urodynamic 236

Urological cancers 280

Ventriculoperitoneal shunt 280

Visual analog score 138

Vitamin D 83

Wilms tumor 276

Xp11 translocation 122

Yolk sac tumor 200